Caprock Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,704
Closed -$362K 997
2024
Q3
$362K Sell
5,704
-172
-3% -$12.4K 0.01% 662
2024
Q2
$397K Buy
5,876
+89
+2% +$6.21K 0.02% 609
2024
Q1
$458K Hold
5,787
0.03% 440
2023
Q4
$450K Buy
5,787
+12
+0.2% +$888 0.03% 419
2023
Q3
$406K Buy
5,775
+12
+0.2% +$897 0.03% 416
2023
Q2
$459K Sell
5,763
-34
-0.6% -$2.46K 0.03% 393
2023
Q1
$419K Sell
5,797
-83
-1% -$6.47K 0.03% 404
2022
Q4
$484K Buy
5,880
+112
+2% +$9.23K 0.05% 289
2022
Q3
$451K Buy
5,768
+18
+0.3% +$1.44K 0.04% 299
2022
Q2
$389K Hold
5,750
0.04% 316
2022
Q1
$377K Hold
5,750
0.04% 354
2021
Q4
$349K Sell
5,750
-140
-2% -$8.35K 0.03% 374
2021
Q3
$376K Buy
+5,890
New +$372K 0.03% 324

Other funds holding ACHC

Caprock Group's ACHC Position: Q4 2024 in Review

Caprock Group sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 5,704 shares — an estimated $362K sold.

Caprock Group first reported a position in ACHC in Q3 2021 and held it in 13 quarters. The position peaked at $484K in Q4 2022. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Caprock Group reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Caprock Group sold 5,704 Acadia Healthcare shares in Q4 2024, an estimated $362K.
  • Caprock Group first reported a position in Acadia Healthcare in Q3 2021 and held it in 13 quarters.
  • Caprock Group's Acadia Healthcare position peaked at $484K in Q4 2022.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Caprock Group's 13F filing for Q4 2024, filed 23 Jan 2025.